FDA Accredits the SynCardia Total Artificial Heart With SynHall Valves

by Vishnuprasad on  August 11, 2014 at 6:34 PM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

SynCardia (Tucson, AZ) has gained FDA approval for its SynCardia Total Artificial Heart with SynHall valves, the last of the approvals required to manufacture the hearts for sale in the U.S. The approval was given on July 2, 2104.
 FDA Accredits the SynCardia Total Artificial Heart With SynHall Valves
FDA Accredits the SynCardia Total Artificial Heart With SynHall Valves

The device has recently been approved in Canada and Europe. The SynHall valves, made of titanium and pyrolytic carbon, are nearly identical to the tilting-disk valves used with the Total Artificial Heart in the past.

The company claimed that after more than 1,300 artificial heart implants that involved more than 5,000 of the valves, not one failure has been reported.

"We're delighted that the SynHall valves passed the FDA's rigorous approval process," says Michael P. Garippa, SynCardia CEO and President.

The company also controls manufacture of segmented polyurethane solution (SPUS), which is used in the SynCardia Total Artificial Heart's housings, diaphragms and connectors. SynCardia is the only source of SPUS in the world.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Pericarditis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive